This ruling removes a material coverage liability for WRB and reinforces the enforceability of capacity exclusions in D&O policies under New Jersey law. However, the dissent and unresolved factual issues on withholding consent to settle suggest some residual litigation risk on remand for Berkley's unreimbursed defense costs.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 12 $65.87entry
- T+1 · 6mo ago −1.70%α −2.26% · $64.75
- T+5 · 6mo ago +2.94%α +3.55% · $67.81
- T+20 · 5mo ago +2.39%α +4.12% · $67.44
- T+60 · 3mo ago +8.54%α +3.52% · $71.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The New Jersey Supreme Court ruled that Berkley Insurance Company validly denied coverage to Mist Pharmaceuticals under a D&O policy's capacity exclusion, holding that the claims against Mist Pharmaceuticals solely involved Krivulka's wrongful acts in an uninsured capacity (as a director of Akrimax). The Court affirmed the Appellate Division's reversal of the trial court's $1.75M judgment against Berkley, finding Berkley properly reserved its rights and did not forfeit coverage defenses by withholding consent to settle. This is a clear legal win for Berkley, removing a ~$2.5M liability and confirming that its policy exclusion language is enforceable.
Court Ruling Details
Key Facts
- New Jersey Supreme Court held that Berkley's D&O capacity exclusion unambiguously bars coverage for Mist Pharmaceuticals' claims because all underlying allegations involved Krivulka's wrongful acts as a director/member of uninsured entities (Akrimax, Mist Acquisition, etc.)
- Court found Berkley did not forfeit its right to rely on the capacity exclusion; it repeatedly reserved rights in letters and emails at least 10 times over 5 years
- Court rejected estoppel argument under Griggs v. Bertram, noting Berkley gave timely notice of potential disclaimer unlike the insurer in that case
- Court distinguished Fireman's Fund Insurance Co. v. Security Insurance Co., finding no bad faith or breach because Berkley correctly determined the policy did not cover the claims
- Dissent by Justice Fasciale argued Berkley's conduct estopped it from relying on the exclusion and that the exclusion does not bar all coverage when an insured acts in dual capacities
Financial Impact
Eliminates $1.75M judgment against Berkley plus $796K in legal fees; policy limit exposure of $2M removed
Risk Factors
- Dissent raises possibility of remand for factual determinations on whether Berkley unreasonably withheld consent to settle
- Mist Pharmaceuticals may seek certiorari to U.S. Supreme Court (though unlikely given state-law grounding)
- Claim of $300M settlement exposure in underlying case could resurface via other theories if coverage ruling is overturned on rehearing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-fbhddsn5-WRB |
Track record
11 reports on WRB
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 2, 202614d ago S-3ASR Neutral 2/10 Entry $75.12 to $76.83 Now $78.52 +4.53% ▲ +2.28% +2.86% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $73.86 to $75.23 Now $78.52 +6.31% ▲ +1.85% +4.56% vs SPY
- Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $73.10 to $76.98 Now $78.52 +7.41% ▲ +5.31% +10.03% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $71.63 to $76.71 Now $78.52 +9.62% ▲ +7.09% +7.80% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $73.15 to $72.38 Now $78.52 −7.34% ▲ +1.05% +1.13% vs SPY
- Jun 26, 202620w ago 8-K Neutral 2/10 Entry $71.01 to $70.92 Now $78.52 +10.58% ▼ −0.13% −1.51% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $68.27 to $67.18 Now $78.52 +15.01% ▼ −1.60% −2.27% vs SPY
- Jun 10, 202622w ago 8-K Neutral 4/10 Entry $15.34 Now $78.52 +411.86% No price data
- May 11, 202627w ago Court Ruling Bullish 6/10 Viewing Entry $65.87 to $67.81 Now $78.52 +19.20% ▲ +2.94% +3.55% vs SPY
- Apr 21, 202629w ago 8-K Bullish 8/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers